Genomically, HNSCC tumors are dominated by mutations resulting through altered patterns of APOBEC activity, but the landscape of mutational drivers is overall highly heterogeneous, similarly to that reported by previous TCGA studies, with TP53 and CDKN2A as major drivers (4). This evidence concerns the gene TP53 and head and neck squamous cell carcinoma.